Delivery Order SPE2DB22D3301-SPE2DB25FY8PS
Award Date 7/31/25
Potential Completion Date 8/1/25
Potential Value $48K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,599.62 delivery order to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampules (2.5 ml) on September 9, 2025, with completion expected by September 10, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a single delivery order against AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency has awarded a delivery order valued at $18,388.41 to AmerisourceBergen Drug Corp for the supply of Pulmozyme 1 mg/ml ampules (2.5 ml vials). This firm fixed-price, non-set-aside delivery order was awarded on May 8, 2025, with an ultimate completion date of May 9, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. This award represents a...
- The Defense Logistics Agency awarded a $11.9K delivery order to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/mL ampul 2.5mL pharmaceutical product, with an ultimate completion date of July 28, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $9.68K delivery order to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/mL ampules (2.5 mL units) on July 23, 2025, with completion expected by July 24, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99M vehicle extending through...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,805.20 to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/ml ampules (2.5ml) on March 12, 2025, with an ultimate completion date of March 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $11,261.88 to AmerisourceBergen Drug Corp for the supply of Pulmozyme 1 mg/ml ampules (2.5 ml units). The contract is a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, issued on September 8, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was not issued under any set-aside designation and was competitively awarded. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,348.64 to AmerisourceBergen Drug Corp for the supply of Pulmozyme 1 mg/ml ampul 2.5ml, a pharmaceutical product used in respiratory treatment. This firm fixed-price delivery order, awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $40,007.44 to supply Pulmozyme 1 mg/ml ampules (2.5 ml units), a pharmaceutical product used in respiratory care. This firm fixed-price delivery order, awarded on August 12, 2025, with completion scheduled for August 13, 2025, was competitively awarded without set-aside designation. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $11,346.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Pulmozyme 1 mg/ml ampuls in 2.5 ml units. The contract, with an ultimate completion date of September 15, 2025, carries no set-aside designation and represents a competitive award under AmerisourceBergen's existing federal pharmaceutical supply agreements. Performance will be executed from the contractor's Corporate Office location in...
- The Defense Logistics Agency (DLA) awarded a $6,994.78 firm fixed price delivery order to AmerisourceBergen Drug Corp for Pulmozyme 1 mg/mL ampuls (2.5 mL units). The contract, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-set-aside competitive award. Performance will take place at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...